C

Cardurion Pharmaceuticals

29 employees

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Cardiovascular
Therapeutics
Heart Failure
Medical
Pharmaceutical
Cardiology

Date founded

2017

Funding rounds raised

Total raised

$300M

from 2 investors over 2 rounds

C

Cardurion Pharmaceuticals raised $300M on October 27, 2021

Investors: Polaris Partners

C

Cardurion Pharmaceuticals raised undisclosed on November 20, 2019

Investors: Polaris Partners

FAQ